VISTAGEN THERAPEUTICS, INC. Accrued Liabilities, Current
VISTAGEN THERAPEUTICS, INC. (VTGN) had Accrued Liabilities, Current of $9.24 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $9.24M.
- 2026-03-31: Accrued Liabilities, Current $8.76M.
- 2025-12-31: Accrued Liabilities, Current $9.25M.
- 2025-09-30: Accrued Liabilities, Current $8.42M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $9.24M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $8.76M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $9.25M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $8.42M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.58M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $8.81M 10-K · filed 2026-06-15 | |
| 2024-12-31 | $5.47M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $3.81M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.16M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.23M 10-K · filed 2025-06-17 | |
| 2023-12-31 | $129.30K 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $292.60K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $424.70K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $796.00K 10-K · filed 2024-06-11 | $787.40K 10-K · filed 2023-06-28 |
| 2022-12-31 | $1.09M 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $1.19M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $727.30K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.33M 10-K · filed 2023-06-28 | |
| 2021-12-31 | $2.63M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $3.43M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $2.15M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.56M 10-K · filed 2022-06-23 | |
| 2020-12-31 | $507.20K 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $186.90K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.15M 10-Q · filed 2021-08-12 | $607.80K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $561.50K 10-K · filed 2021-06-29 | |
| 2019-12-31 | $951.30K 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $2.22M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.85M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $1.69M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $827.10K 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $599.70K 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $1.06M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $206.30K 10-K · filed 2019-06-25 | |
| 2017-12-31 | $770.90K 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $625.60K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $204.90K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $443.00K 10-K · filed 2018-06-26 | |
| 2016-12-31 | $961.80K 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $795.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $564.80K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $814.00K 10-K · filed 2017-06-29 | |
| 2015-12-31 | $929.10K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $1.13M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $1.38M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $1.21M 10-K · filed 2016-06-24 | |
| 2014-12-31 | $1.19M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $857.40K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $810.20K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $625.60K 10-K · filed 2015-06-29 | |
| 2013-12-31 | $532.50K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $462.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $371.30K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $625.60K 10-Q · filed 2014-11-19 | $342.90K 10-K · filed 2013-07-18 |
| 2012-12-31 | $382.30K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $394.40K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $630.20K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $342.90K 10-Q · filed 2013-11-14 | $657.30K 10-K · filed 2012-07-02 |
| 2011-12-31 | $452.83K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $431.60K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $445.38K 10-Q · filed 2011-08-22 | |
| 2011-03-31 | $1.42M 10-K · filed 2012-07-02 | $1.42M 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |